相关实验视频

Updated: Jul 4, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

反S层单克隆抗体对 Clostridioides difficile 生理学的影响

Lise Hunault^1,2,3, Emile Auria⁴, Patrick England⁵

¹Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.

|January 30, 2024

概括

针对Clostridioides difficile S层蛋白A (SlpA) 的单克隆抗体揭示了它在细菌生长和毒性中的作用. 这些抗体可以对感染结果产生多种影响,影响C. difficile感染的治疗策略.

科学领域:

微生物学微生物学
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

困难菌 (C. difficile) 是医院获得的腹的主要原因,其复发率和死亡率很高.
表面 (S) 层蛋白A (SlpA) 在C. difficile上大量存在,并与感染有关,但其确切的功能尚不清楚.
在康复的患者中发现了抗S层抗体,但它们对C. difficile感染 (CDI) 的保护机制尚不清楚.

研究的目的:

产生和鉴定针对C. difficileS层蛋白A (SlpA) 的单克隆抗体 (mAbs).
研究SlpA在C. difficile生理学中的作用,包括生长,毒素分泌和生物膜形成.
探索在CDI中针对SlpA的潜在治疗影响.

主要方法:

对C. difficile参考菌株630的S层产生单克隆抗体.
对抗SlpA mAbs对它们对细菌生长,毒素分泌和生物膜形成的影响的表征.
对一种抗SlpA mAb对C. difficile对酶诱导的溶解敏感性的影响进行评估.

主要成果:

针对SlpA的单克隆抗体对C. difficile生长,毒素分泌和生物膜形成产生了多种影响.
特定的抗SlpA mAbs对这些细菌功能产生了差异的影响,有些表现出相反的效果.
发现一种抗SlpA mAb可以抑制C. difficile的生长并增加对lyszyme的敏感性,这表明它对细菌活力有直接影响.

结论:

这项研究提供了对C. difficile SlpA的第一个mAbs,揭示了它在细菌生理学的多方面的作用.
在CDI期间的Anti-SlpA抗体反应可以对宿主有益或有害.
这些发现为开发针对C. difficileS层的新疗法提供了关键的见解.

关键词:

克洛斯特里迪奥伊德斯困难菌在 S 层中,生物膜是一种生物膜.增长的增长增长的增长增长的增长.一个单克隆抗体.中性粒细胞中性粒细胞.有毒物质有毒物质的毒素.

更多相关视频

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

相关概念视频

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Surface Membrane Barriers

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...